Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;25(10):1831-1839.
doi: 10.1002/ejhf.2944. Epub 2023 Jul 26.

Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fraction

Affiliations

Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fraction

Mingming Yang et al. Eur J Heart Fail. 2023 Oct.

Abstract

Aim: Although education in self-management is thought to be an important aspect of the care of patients with heart failure, little is known about whether self-rated knowledge of self-management is associated with outcomes. The aim of this study was to assess the relationship between patient-reported knowledge of self-management and clinical outcomes in patients with heart failure and reduced ejection fraction (HFrEF).

Methods and results: Using individual patient data from three recent clinical trials enrolling participants with HFrEF, we examined patient characteristics and clinical outcomes according to responses to the 'self-efficacy' questions of the Kansas City Cardiomyopathy Questionnaire. One question quantifies patients' understanding of how to prevent heart failure exacerbations ('prevention' question) and the other how to manage complications when they arise ('response' question). Self-reported answers from patients were pragmatically divided into: poor (do not understand at all, do not understand very well, somewhat understand), fair (mostly understand), and good (completely understand). Cox-proportional hazard models were used to evaluate time-to-first occurrence of each endpoint, and negative binomial regression analysis was performed to compare the composite of total (first and repeat) heart failure hospitalizations and cardiovascular death across the above-defined groups. Of patients (n = 17 629) completing the 'prevention' question, 4197 (23.8%), 6897 (39.1%), and 6535 (37.1%) patients had poor, fair, and good self-rated knowledge, respectively. Of those completing the 'response' question (n = 17 637), 4033 (22.9%), 5463 (31.0%), and 8141 (46.2%) patients had poor, fair, and good self-rated knowledge, respectively. For both questions, patients with 'poor' knowledge were older, more often female, and had a worse heart failure profile but similar treatment. The rates (95% confidence interval) per 100 person-years for the primary composite outcome for 'poor', 'moderate' and 'good' self-rated knowledge in answer to the 'prevention' question were 12.83 (12.11-13.60), 12.08 (11.53-12.65) and 11.55 (11.00-12.12), respectively, and for the 'response' question were 12.88 (12.13-13.67), 12.22 (11.60-12.86) and 11.56 (11.07-12.07), respectively. The lower event rates in patients with 'good' self-rate knowledge were accounted for by lower rates of cardiovascular (and all-cause) death and not hospitalization for worsening heart failure.

Conclusions: Poor patient-reported 'self-efficacy' may be associated with higher rates of mortality. Evaluation of knowledge of 'self-efficacy' may provide prognostic information and a guide to which patients may benefit from further education about self-management.

Keywords: Heart failure; Kansas City Cardiomyopathy Questionnaire; Self-efficacy; Self-rated knowledge; Symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative incidence of outcomes according to answers to the ‘prevention’ self‐care Kansas City Cardiomyopathy Questionnaire question in patients with heart failure (HF) and reduced ejection fraction. (A) Cardiovascular (CV) death or first HF hospitalization; (B) first HF hospitalization; (C) CV death; (D) all‐cause death.
Figure 2
Figure 2
Cumulative incidence of outcomes according to answers to the ‘response’ self‐care Kansas City Cardiomyopathy Questionnaire question in patients with heart failure (HF) and reduced ejection fraction. (A) Cardiovascular (CV) death or first HF hospitalization; (B) first HF hospitalization; (C) CV death; (D) all‐cause death.

Comment in

References

    1. Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state‐of‐the‐art review. J Am Coll Cardiol 2020;76:2379–2390. 10.1016/j.jacc.2020.09.542 - DOI - PubMed
    1. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245–1255. 10.1016/s0735-1097(00)00531-3 - DOI - PubMed
    1. Joseph SM, Novak E, Arnold SV, Jones PG, Khattak H, Platts AE, et al. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circ Heart Fail 2013;6:1139–1146. 10.1161/circheartfailure.113.000359 - DOI - PMC - PubMed
    1. Napier R, McNulty SE, Eton DT, Redfield MM, AbouEzzeddine O, Dunlay SM. Comparing measures to assess health‐related quality of life in heart failure with preserved ejection fraction. JACC Heart Fail 2018;6:552–560. 10.1016/j.jchf.2018.02.006 - DOI - PMC - PubMed
    1. Rector TS, Carson PE, Anand IS, McMurray JJ, Zile MR, McKelvie RS, et al.; I‐PRESERVE Trial Investigators . Assessment of long‐term effects of irbesartan on heart failure with preserved ejection fraction as measured by the Minnesota Living with Heart Failure Questionnaire in the Irbesartan in Heart Failure with Preserved Systolic Function (I‐PRESERVE) trial. Circ Heart Fail 2012;5:217–225. 10.1161/circheartfailure.111.964221 - DOI - PubMed

Publication types